2019 | | Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression | 강석윤, 김장희, 박태준, 최용원 |
2012 | | Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer | 소의영 |
2014 | | B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1. | 김장희, 박태준, 소의영, 이정훈, 최용원, 최용준 |
2015 | | BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma. | 김장희 |
2015 | | BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas. | 이다근 |
2013 | | Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. | 조남한 |
2016 | | Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules | 하은주 |
2016 | | MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers | 김영배, 서광욱, 이다근, 이현우, 최용원 |
2021 | | Molecular correlates and nuclear features of encapsulated follicular-patterned thyroid neoplasms | 김장희 |
2018 | | mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas | 장전엽 |
2021 | | New approach of prediction of recurrence in thyroid cancer patients using machine learning | 김수영 |
2021 | | Presence of TERT ± BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma | 김형규, 노진, 이정훈, 하은주 |
2015 | | Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer. | 김장희, 소의영, 안영실, 윤준기, 이수진, 정윤석 |
2015 | | Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma. | 김장희, 박태준, 소의영, 이정훈, 최용원 |
2014 | | TSH signaling overcomes B-RafV600E-induced senescence in papillary thyroid carcinogenesis through regulation of DUSP6. | 김장희, 박태준, 소의영, 이정훈, 한재호 |
2015 | | VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases. | 김대중, 김장희, 소의영, 신승수, 이기범, 이정훈, 임현이, 정선용, 정윤석, 한재호 |